|
Symposia
&
Workshops
Symposium
1:
Bone
and
fat
Moustapha
Kassem
(Odense,
Denmark)
Osteoblasts
and
adipocytes:
human
skeletal
(mesenchymal)
stem
cells
lineage
fate
regulation
Clifford
Rosen
(Portland,
USA)
Lessons
from
genetic
models
Symposium
2:
Bone
and
bone
marrow
Gregor
Adams (Los
Angeles,
USA)
Hematopoietic
stem
cells
and
bone
Stephen
Emerson (Haverford,
USA)
Osteoblasts
in
hematopoiesis
and
lymphopoiesis
Symposium
3:
Bone
and
blood
vessels
Bjorn
Olsen
(Boston,
USA)
VEGF
in
bone
development
and
homeostasis
Ewa
Paleolog
(London,
UK)
Role
of
angiogenesis
in
bone
and
joint
diseases
Symposium
4:
Bone
and
muscle
(ECTS/ASBMR
Joint
Session)
Shalender
Bhasin (Boston,
USA)
Testosterone
for
sarcopenia
Leonard
Freedman (Philadelphia,
USA)
Frailty:
molecular
and
therapeutic
approaches
Symposium
5:
Osteocytes
and
mineral
metabolism
Paola
Divieti
Pajevic
(Boston,
USA)
Osteocytes
and
calcium
homeostasis
Darryl
Quarles
(Memphis,
USA)
FGF23:
paradigm
shift
in
understanding
and
treating
disordered
mineral
metabolism
in
CKD
Symposium
6:
Micro
RNAs
in
bone
biology
Eran
Hornstein
(Rehovot,
Israel)
A
miRNA
mechanism
for
repression
of
osteoclast
differentiation
Jane
Lian
(Worcester,
USA)
Significance
of
microRNA
control
of
bone
formation
and
homeostasis
Symposium
7:
Bone
and
gut
Gerard
Karsenty
(New
York,
USA)
Regulation
of
bone
formation
by
gut-derived
serotonin
(ECTS
Excellence
in
Research
Lecture)
Dennis
Henriksen
(Copenhagen,
Denmark)
Gut,
glucagon
like
peptide-2
and
bone
Workshop
1:
Advances
in
imaging
of
the
spine
Lynne
Ferrar
(Sheffield,
UK)
Using
DXA
for
vertebral
fracture
analysis
Claus
Glüer
(Kiel,
Germany)
Using
QCT
for
high
resolution
evaluation
of
vertebrae
Christian
Roux
(Paris,
France)
Using
VFA
for
3D
reconstruction
of
the
vertebrae
:
the
3DXA
method
Workshop
2:
Wnt
signaling
in
health
and
disease
Marc de la Roche
(Cambridge,
UK)
Nuclear
WNT
signaling
components
and
their
potential
as
cancer
drug
targets
Cara
Gottardi
(Chicago,
USA)
Adhesion
signaling
via
catenins
Michaela
Kneissel
(Basel,
Switzerland)
Wnt
signaling
and
anabolic
bone
strategies
Workshop
3:
Circadian
rhythms:
impact
on
bone
cells
and
markers
Paul
Frenette
(New
York,
USA)
Circadian
regulation
of
a
stem
cell
niche
Shu
Takeda
(Tokyo,
Japan)
Regulation
of
bone
remodelling
by
circadian
genes
William
Fraser
(Liverpool,
UK)
Circadian
rhythms
and
bone
remodelling/markers
Workshop
4:
New
approaches
in
osteoarthritis
Frank
Luyten
(Leuven,
Belgium)
Regenerative
treatments
in
osteoarthritis
Tim
Spector
(London,
UK)
The
genetics
of
osteoarthritis
and
clues
to
bone
and
cartilage
biology
Sharmila
Majumdar
(San
Francisco,
USA)
New
approaches
to
imaging
of
articular
cartilage
Workshop
5:
Cortical
bone
in
health
and
disease
Roger
Zebaze
(Melbourne,
Australia)
Cortical
bone
mass
and
turnover
Heather
McKay
(Vancouver,
Canada)
Winning
the
battle
against
childhood
physical
inactivity
Stephen
Kaptoge
(Cambridge,
UK)
Limb
fractures:
epidemiology
and
predictive
value
of
BMD
and
cortical
bone
measurements
Workshop
6:
New
approaches
to
PTH
anabolic
treatment:
calcilytics
Rajesh
Thakker
(Oxford,
UK)
The
calcium
sensing
receptor
Edward
Nemeth
(Toronto,
Canada)
Preclinical
studies
with
calcilytic
compounds
Markus
John
(Basel,
Switzerland)
Translational
and
clinical
studies
on
calcilytics
|
